Delivery Order SPE2DB22D1017-SPE2DB24FG2JC
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $16,253.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564742986 - Sorafenib 200 mg Tablets in 120-count bottles, with a completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $37,169.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of 120 tablets of Sorafenib 200 mg, a prescription medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp is a division of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company is a leading...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sorafenib 200 mg tablets and has a ceiling value of $9,378.30. It is a firm fixed-price contract with a completion date of May 25, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,371.84, is for the delivery of 120 tablets of the medication Sorafenib 200 mg. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award, SPE2DB20D3103|SPE2DB25FN1T9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,603.82 firm fixed-price delivery order is for the supply of 4567678535 SORAFENIB 200 MG TABLET 120S. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $56,142.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CABOMETYX 20 MG TABLET 30S, a pharmaceutical product. The contract has a performance period through July 30, 2024 and is a firm-fixed price delivery order. This contract is not associated with any set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This federal contract award, valued at $15,346.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors in the world, is for the delivery of CABOMETYX 20 MG TABLET 30S to the Defense Logistics Agency (DLA). The $14,035.64 firm fixed-price delivery order has an ultimate completion date of August 1, 2024. The contract is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,346.44 firm fixed-price delivery order is for the supply of CABOMETYX 40 MG TABLET 30S, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $13,867.18 firm-fixed price delivery order is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of a larger Indefinite Delivery Contract (IDC) with...